New Transcription Factors And Their Role In Diabetes And Therapy: Advances In Molecular And…

Other | August 1, 2006

byFriedman, Jacob E., Jacob E. Friedman

not yet rated|write a review
This book contains contributions from some of the most eminent experts in the fields of genetics, biochemistry, and pathophysiology of diabetes. Through specific examples, with broad applications, this book provides a comprehensive look at how transcription factors may underline the pathogenetic mechanisms of diabetes and obesity.

Volume 5 provides an overview of the status of the field, while also providing valuable information of practical utility to those who do not necessarily work in this field. The integration of basic biology with physiologically and clinically relevant proteins should provide the reader with a theoretical background to understanding the strategies for new potential therapeutic targets and their application to disease.

*Applies molecular biology to transcriptional regulation of metabolism and obesity
*Underscores the clinical relevance of transcription factors
*Provides a valuable overview of the current status of the field

Pricing and Purchase Info

$176.89 online
$229.66 list price (save 22%)
In stock online
Ships free on orders over $25

From the Publisher

This book contains contributions from some of the most eminent experts in the fields of genetics, biochemistry, and pathophysiology of diabetes. Through specific examples, with broad applications, this book provides a comprehensive look at how transcription factors may underline the pathogenetic mechanisms of diabetes and obesity. V...

Format:OtherDimensions:332 pages, 1 × 1 × 1 inPublished:August 1, 2006Publisher:Elsevier ScienceLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:008046355X

ISBN - 13:9780080463551

Customer Reviews of New Transcription Factors And Their Role In Diabetes And Therapy: Advances In Molecular And Cellular Endocrinology

Reviews

Extra Content

Table of Contents

1. PPARs as therapeutic targets for treating diabetes and insulin resistance
2. Genetic regulators of human obesity and diabetes
3. NF-kb, insulin resistance and the actions of salicylates
4. Wnt signaling and C/EBPs role in adipogenesis
5. Regulation of hepatic gluconeogenesis C/EPBs
6. Forkhead proteins and regulation of hepatic gene expression
7. Control of mitochondrial biogenesis through PGC-1
8. Regulation of PGC-1 in humans in insulin resistance and diabetes: Functional implications
9. FOXC2 controls resistance to obesity and Type II diabetes
10. SREB-1C regulation of nutrient homeostasis and lipid accumulation
11. GATA proteins as molecular gatekeeprs of the adipocyte
12. Diabetes regulation of gene expression by CREB
13. Molecular etiologies of MODY and other early-onset forms of diabetes
14. Liver X receptors as potential drug targets for Diabetes and its disorders
15. The potential therapeutic use of PPAR beta/delta agonists in lipid and glucose homeostasis
16. Influences of new PPAR insulin sensitizers on the metabolic syndrome in Rhesus Monkeys
17. PPARgamma and metabolism: Insights from the study of human genetic variants